Fiduciary Trust CO Gilead Sciences, Inc. Transaction History

Fiduciary Trust CO

$7.39 Billion
Q1 2025

A detailed history of Fiduciary Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fiduciary Trust CO holds 12,797 shares of GILD stock, worth $1.47 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

12,797

Previous 12,647 1.19%

Holding current value

$1.47 Million

Previous $1.17 Million 22.69%

% of portfolio

0.02%

Previous 0.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$89.14 - $117.41 $13,371 - $17,611	150 Added 1.19%	12,797 $1.43 Million
Q4 2024 Feb 14, 2025	SELL	$83.95 - $97.9 $65,229 - $76,068	-777 Reduced 5.79%	12,647 $1.17 Million
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $186,918 - $235,759	2,807 Added 26.44%	13,424 $1.13 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $257,083 - $296,694	-4,071 Reduced 27.72%	10,617 $728,000
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $29,848 - $36,399	-417 Reduced 2.76%	14,688 $1.08 Million
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $54,439 - $61,735	-743 Reduced 4.69%	15,105 $1.22 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $53,976 - $58,889	730 Added 4.83%	15,848 $1.19 Million
Q2 2023 Aug 01, 2023	SELL	$76.01 - $86.7 $94,784 - $108,114	-1,247 Reduced 7.62%	15,118 $1.17 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $22,419 - $25,543	-290 Reduced 1.74%	16,365 $1.36 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $23,930 - $34,356	-384 Reduced 2.25%	16,655 $1.43 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $7,144 - $8,161	-120 Reduced 0.7%	17,039 $1.05 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $26,435 - $29,774	-458 Reduced 2.6%	17,159 $1.06 Million
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $16,217 - $20,322	-280 Reduced 1.56%	17,617 $1.05 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $36,527 - $41,459	-563 Reduced 3.05%	17,897 $1.3 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $66,742 - $72,007	-986 Reduced 5.07%	18,460 $1.29 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $80,479 - $87,935	-1,268 Reduced 6.12%	19,446 $1.34 Million
Q1 2021 May 19, 2021	BUY	$60.0 - $68.46 $17,100 - $19,511	285 Added 1.4%	20,714 $1.34 Million
Q4 2020 Jan 26, 2021	SELL	$56.65 - $64.55 $688,127 - $784,088	-12,147 Reduced 37.29%	20,429 $1.19 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $68,558 - $86,200	-1,104 Reduced 3.28%	32,576 $2.06 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $73,497 - $85,344	1,016 Added 3.11%	33,680 $2.59 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $148,746 - $190,522	-2,375 Reduced 6.78%	32,664 $2.44 Million
Q4 2019 Feb 04, 2020	SELL	$61.62 - $67.78 $249,869 - $274,847	-4,055 Reduced 10.37%	35,039 $2.28 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $210,283 - $232,116	-3,364 Reduced 7.92%	39,094 $2.48 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $237,209 - $266,002	-3,834 Reduced 8.28%	42,458 $2.87 Million
Q1 2019 May 07, 2019	SELL	$62.53 - $70.05 $649,999 - $728,169	-10,395 Reduced 18.34%	46,292 $3.01 Million
Q4 2018 Jan 29, 2019	SELL	$60.54 - $79.0 $1.52 Million - $1.98 Million	-25,025 Reduced 30.63%	56,687 $3.55 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $301,086 - $333,358	-4,224 Reduced 4.92%	81,712 $6.31 Million
Q2 2018 Aug 03, 2018	SELL	$64.88 - $75.68 $363,068 - $423,505	-5,596 Reduced 6.11%	85,936 $6.09 Million
Q1 2018 May 08, 2018	SELL	$72.84 - $88.8 $710,481 - $866,155	-9,754 Reduced 9.63%	91,532 $6.9 Million
Q4 2017 Jan 29, 2018	SELL	$71.15 - $83.52 $1.18 Million - $1.38 Million	-16,525 Reduced 14.03%	101,286 $7.26 Million
Q3 2017 Nov 02, 2017	BUY	$72.11 - $85.47 $8.5 Million - $10.1 Million	117,811	117,811 $9.55 Million

Others Institutions Holding GILD

# of Institutions

2,297

Shares Held

Call Options Held

9.6M

Put Options Held

10.1M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $144B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.

Account

Fiduciary Trust CO Gilead Sciences, Inc. Transaction History